WR 151327

Known as: 1-Propanethiol, 3-((3-(methylamino)propyl)amino)-, dihydrogen phosphate (ester), WR-151327 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2015
02419862015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The effect of combining a radiation-protective phosphorothioate with another agent was investigated in an attempt to increase… (More)
Is this relevant?
2000
2000
PURPOSE To determine the efficacy of WR-151327 (WR) [S-3-(3-methylaminopropylamino) propylphosphorothioic acid; (CH3-HN-(CH2)3-NH… (More)
Is this relevant?
1994
1994
Clinical trials are in progress to evaluate radio- and chemoprotection by the aminothiol 2-[(3-aminopropyl)amino]ethanethiol… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
1994
1994
Reducing agents such as glutathione (GSH), glutathione ester (GSE), and N-acetylcysteine (NAC) have been shown to suppress the… (More)
Is this relevant?
1994
1994
Spaceflight personnel need treatment options that would enhance survival from radiation and would not disrupt task performance… (More)
Is this relevant?
1992
1992
Two thiophosphoroate compounds WR-2721 and WR-151327 were assessed for their ability to modify the deleterious effects (life… (More)
Is this relevant?
1991
1991
The mutagenic and carcinogenic properties of fission-spectrum neutrons (KERMA-weighted mean energy of 0.85 MeV) from Argonne… (More)
Is this relevant?
1990
1990
The systemic effects of the radiation protective agent, S-3-(3-methylaminopropylamino) propylphosphorothioic acid (WR-151327… (More)
Is this relevant?
1987
1987
Two phosphorothioate compounds, WR-2721 and WR-151327, were examined for their radioprotective efficacies against the effects of… (More)
Is this relevant?
1986
1986
Two thiophosphoroate radiation protectors (WR-2721 and WR-151327) were assessed for their ability to modify the effects of… (More)
Is this relevant?